Latest News

ICYMI: Rubio Joins The Aaron Renn Show

U.S. Senator Marco Rubio (R-FL) joined The Aaron Renn Show to discuss Rubio’s Labor Day report on working (and non-working) men. See below for highlights and listen to the full interview here. On protecting American jobs and interests: “We made a series of economic...

read more

ICYMI: Rubio Debates Coons on China, Environment

U.S. Senator Marco Rubio (R-FL) debated Senator Chris Coons (D-DE) on China, global leadership, and environmental policy at an event hosted by the Bipartisan Policy Center’s Senate Project at George Washington University. “We have to shape a future that recognizes...

read more

Next Week: Rubio Staff Hosts Mobile Office Hours

U.S. Senator Marco Rubio’s (R-FL) office will host in-person and virtual Mobile Office Hours next week to assist constituents with federal casework issues in their respective local communities. These office hours offer constituents who do not live close to one of...

read more

Rubio Habla en Maxima 92.5 de Tampa Bay

El senador estadounidense Marco Rubio (R-FL) habló con Nio Encendio de Maxima 92.5 de Tampa Bay, sobre cómo la inflación ha impactado a las familias, sobre las olas de migración ilegal, sobre el juicio político de Biden vs. el de Trump, sobre el canje de prisioneros...

read more

Rubio Applauds Trump Administration’s Actions on Human Fetal Tissue From Elective Abortions

Jun 5, 2019 | Press Releases

Washington, D.C. — Today, U.S. Senator Marco Rubio (R-FL) applauded the Trump administration’s action to protect the dignity of human life from the moment of conception to natural death. The Department of Health and Human Services (HHS) announced today that its contract with the University of California, San Francisco regarding research involving human fetal tissue from elective abortions, which expires today on June 5, 2019, will not be renewed.
“The federal government should never be complicit in the horrific scheme of buying fetal tissue from aborted babies,” Rubio said. “I commend the Trump administration for protecting the dignity of human life by ending contracts that provide the fetal tissue of aborted babies for federally funded research.”
HHS also announced plans to undertake changes to its regulations and National Institutes of Health (NIH) grants policy to adopt or strengthen safeguards and program integrity requirements applicable to extramural research involving human fetal tissue. HHS will continue to review whether adequate alternatives exist to the use of human fetal tissue from elective abortions in HHS-funded research and will ensure that efforts to develop such alternatives are funded and accelerated. In December 2018, NIH announced a $20 million funding opportunity for research to develop, demonstrate, and validate experimental models that do not rely on human fetal tissue from elective abortions.